HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 216.25M
Enterprise Value 265.98M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.92
Price/Book (mrq)2.99
Enterprise Value/Revenue 2.32
Enterprise Value/EBITDA 34.12

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 352.80%
S&P500 52-Week Change 33.90%
52 Week High 36.29
52 Week Low 31.98
50-Day Moving Average 35.14
200-Day Moving Average 33.33

Share Statistics

Avg Vol (3 month) 3200.17k
Avg Vol (10 day) 3203.87k
Shares Outstanding 542.19M
Implied Shares Outstanding 6N/A
Float 833.19M
% Held by Insiders 17.05%
% Held by Institutions 176.24%
Shares Short (May 14, 2023) 4386.67k
Short Ratio (May 14, 2023) 41.57
Short % of Float (May 14, 2023) 40.95%
Short % of Shares Outstanding (May 14, 2023) 40.92%
Shares Short (prior month Apr 13, 2023) 4272.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21319:1000
Last Split Date 3Nov 03, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin -1.76%
Operating Margin (ttm)-1.68%

Management Effectiveness

Return on Assets (ttm)-0.79%
Return on Equity (ttm)-2.67%

Income Statement

Revenue (ttm)114.53M
Revenue Per Share (ttm)2.75
Quarterly Revenue Growth (yoy)4.20%
Gross Profit (ttm)62.29M
Net Income Avi to Common (ttm)-2.01M
Diluted EPS (ttm)-0.05
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.79M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)51.12M
Total Debt/Equity (mrq)68.77
Current Ratio (mrq)2.26
Book Value Per Share (mrq)1.76

Cash Flow Statement

Operating Cash Flow (ttm)4.95M
Levered Free Cash Flow (ttm)8.88M